M&A Deal Summary

Thompson Street Capital Partners Acquires Isto Technologies - Commercial Business

On June 3, 2016, private equity firm Thompson Street Capital Partners acquired life science company Isto Technologies - Commercial Business from ISTO Technologies

Acquisition Highlights
  • This is Thompson Street Capital Partners’ 2nd transaction in the Life Science sector.
  • This is Thompson Street Capital Partners’ 37th transaction in the United States.
  • This is Thompson Street Capital Partners’ 4th transaction in Missouri.

M&A Deal Summary

Date 2016-06-03
Target Isto Technologies - Commercial Business
Sector Life Science
Buyer(s) Thompson Street Capital Partners
Sellers(s) ISTO Technologies
Deal Type Divestiture

Target

Isto Technologies - Commercial Business

St. Louis, Missouri, United States
Isto Technologie's Commercial Business is a provider of unparalleled value proposition by offering evidence-based orthobiologics and leveraging scientific expertise to partner with physicians and improve patient outcomes.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Thompson Street Capital Partners

St. Louis, Missouri, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2001
PE ASSETS 2.6B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Thompson Street Capital Partners is a private equity firm that targets control stakes in profitable, mid-sized North American companies with $5 to $20 million of EBITDA. Thompson Street looks for family businesses, private companies seeking liquidity, corporate divestitures, and public companies going private. Areas of interest include healthcare services, business services, electronics, information technology, and engineered products companies. Thompson Street will not consider investments in start-ups, early stage companies, or real estate. Thompson Street Capital was founded in 2000 and is based in St. Louis, Missouri.


DEAL STATS #
Overall 37 of 73
Sector (Life Science) 2 of 5
Type (Divestiture) 2 of 3
State (Missouri) 4 of 9
Country (United States) 37 of 72
Year (2016) 3 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-06-03 ISTO Biologics

Hopkinton, Massachusetts, United States

ISTO Biologics is a orthobiologics company providing advanced solutions for the spine and orthopedics markets. The company offers an innovative portfolio of products including InQu Bone Graft Extender & Substitute, Influx Trabecular Bone Graft, and CellPoint Concentrated Bone Marrow Aspirate System. ISTO provides an unparalleled value proposition by offering evidence-based orthobiologics and leveraging scientific expertise to partner with physicians and improve patient outcomes. ISTO Biologics was founded in 1997 and is based in Hopkinton, Massachusetts.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-06-27 StayLock Storage

St. Louis, Missouri, United States

StayLock Storage is a provider of self-storage, under the StayLock banner. The facilities feature 916 non-climate controlled storage units and 37 spaces for boat and vehicle parking with five locations in Northwest Indiana. Locations include Demotte, Hebron, Kouts, Wheatfield, and Winfield (Lake of the Four Seasons), Indiana. StayLock Storage was founded in 2016 and is based in St. Louis, Missouri.

Buy -

Seller(S) 1

SELLER

ISTO Technologies

St. Louis, Missouri, United States

Category Company
Founded 1997
Sector Medical Products
DESCRIPTION

ISTO Technologies, Inc. is an orthobiologics company dedicated to improving patient quality of life by using the science of human biology to advance solutions for spine, orthopedics, and sports medicine. ISTO’s products include InQu Bone Graft Extender & Substitute, Influx Trabecular Bone Graft and CellPoint Concentrated Bone Marrow Aspirate System.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
State (Missouri) 1 of 1
Country (United States) 1 of 1
Year (2016) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-10-19 Arteriocyte Medical Systems

Cleveland, Ohio, United States

Arteriocyte Medical Systems, Inc. is a medical device manufacturer of cellular therapy products in the cardiac, orthopedic and vascular surgery market. Arteriocyte's main product is the Magellan Autologous Platelet Separator System purchased from Medtronic.

Buy -